SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
BlackRock Science and Technology Trust II (BSTZ) trades at a trailing P/E of 5.3. Trailing earnings yield is 18.87%. PEG 0.25 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (5.3); PEG ≤ 1.0 — Peter Lynch undervalued (0.25); earnings yield beats bond yields (18.87%).
- PEG Ratio 0.25 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 18.87% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
Overall SharesGrow Score: 79/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — BSTZ
Valuation Multiples
P/E (TTM)5.3
Forward P/EN/A
PEG Ratio0.25
Forward PEGN/A
P/B Ratio0.00
P/S Ratio6.27
EV/EBITDA0.0
Per Share Data
EPS (TTM)$4.57
Book Value / Share$0.00
Revenue / Share$3.87
FCF / Share$0.00
Yields & Fair Value
Earnings Yield18.87%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2019 |
$1.45 |
$113.72M |
$113.23M |
99.6% |
| 2020 |
$19.02 |
$1.49B |
$1.49B |
99.9% |
| 2021 |
$3.18 |
$250.71M |
$248.55M |
99.1% |
| 2022 |
$-16.99 |
$-1.33B |
$-1.34B |
- |
| 2023 |
$3.68 |
$282.21M |
$279.96M |
99.2% |
| 2024 |
$3.77 |
$274.17M |
$272.28M |
99.3% |
| 2025 |
$4.57 |
$265.96M |
$314.36M |
118.2% |
